1. Home
  2. TMCI vs MSD Comparison

TMCI vs MSD Comparison

Compare TMCI & MSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$2.90

Market Cap

174.6M

Sector

Health Care

ML Signal

HOLD

Logo Morgan Stanley Emerging Markets Debt Fund Inc.

MSD

Morgan Stanley Emerging Markets Debt Fund Inc.

HOLD

Current Price

$7.43

Market Cap

150.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMCI
MSD
Founded
2014
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
174.6M
150.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TMCI
MSD
Price
$2.90
$7.43
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$4.21
N/A
AVG Volume (30 Days)
944.3K
70.2K
Earning Date
02-26-2026
01-01-0001
Dividend Yield
N/A
11.26%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$218,879,000.00
N/A
Revenue This Year
$3.25
N/A
Revenue Next Year
$0.99
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.90
N/A
52 Week Low
$2.36
$6.11
52 Week High
$10.79
$7.46

Technical Indicators

Market Signals
Indicator
TMCI
MSD
Relative Strength Index (RSI) 51.42 54.72
Support Level $2.42 $7.37
Resistance Level $3.06 $7.45
Average True Range (ATR) 0.17 0.07
MACD 0.12 -0.00
Stochastic Oscillator 76.43 88.89

Price Performance

Historical Comparison
TMCI
MSD

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About MSD Morgan Stanley Emerging Markets Debt Fund Inc.

Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.

Share on Social Networks: